C. Difficile Toxin A

If you have had three or more loose stools in a day, especially in the weeks after antibiotics or a hospital stay, this result can show whether your stool contains a strain carrying the gene for one of the major C. difficile toxins. That changes what happens next: treatment may be on the table, or the search moves to another cause.

This version of the test uses PCR on a stool sample to look for the gene that makes toxin A, not the toxin protein itself. Many outcome studies measured toxin B genes or combined toxin A/B gene panels. They support the interpretation of toxigenic C. difficile PCR, but they apply most cleanly when this result is paired with toxin B or free-toxin testing.

What the Test Actually Detects

The protein made from this gene is TcdA. It is a large poison produced by Clostridioides difficile, a bacterium that lives in the colon. It works by switching off small control proteins inside intestinal cells that help hold the cell's scaffolding together. The cells round up, the seals between them come apart, the barrier leaks, and inflammation follows. Bad cases can form pseudomembranous colitis, one of the severe patterns that gives this infection its reputation.

The gene for toxin A, called tcdA, sits in a stretch of bacterial DNA that often also carries the gene for its sibling toxin, TcdB. A PCR test amplifies that DNA. So a positive result says one thing precisely: DNA from a strain carrying the toxin A gene is present in the stool sample. It does not say the bacterium is currently making toxin, and it does not prove the toxin is what is causing your symptoms.

That gap is the main thing to understand. About 8% of adults carry toxin-capable C. difficile without illness at the time of hospital admission, and in infants carriage peaks near 14% between 6 and 12 months of age, running lower at other ages. Carriage runs higher in hospitals and care facilities. Test those people and the PCR can light up. That is not the same as disease.

Why Symptoms Have to Come First

A prospective study of 1,416 hospitalized adults compared people who were PCR-positive but had no detectable free toxin in stool against people who were negative on both tests. The two groups behaved almost identically. Complications were rare in both. Treating every PCR-positive result as colitis meant treating many people who did not appear to have it.

This is why diagnostic guidelines say to test only when you have clinically significant diarrhea, and not to test formed stool. A positive PCR in someone with normal bowel movements is a finding about carriage, not a diagnosis. The same logic applies when C. difficile shows up incidentally on a multi-pathogen gastrointestinal panel ordered for other reasons. Those incidental positives drive unnecessary antibiotic prescriptions.

A negative toxin-gene panel that includes toxin B is cleaner to read than a positive result: it makes toxin-producing C. difficile unlikely as the cause of diarrhea. A negative toxin A gene result by itself is narrower. Some strains make toxin B without toxin A and still cause full-blown colitis. In human colon tissue and in bacteria engineered to make only one of the two, toxin B is at least as damaging as toxin A and is on its own enough to cause disease. So toxin A alone cannot be used to rule out infection.

The Two-Step Algorithm and What the Second Step Adds

Because PCR cannot separate infection from carriage, many labs use multistep testing for clinical diagnosis. A typical sequence starts with a sensitive screen, then reflexes to an assay that looks for free toxin protein in the stool, usually an enzyme immunoassay. PCR often serves as the tie-breaker when the first two steps disagree.

The free-toxin step is what the gene test cannot give you. Detecting actual toxin A and B protein tends to track with higher white blood cell counts, longer diarrhea, and more severe disease. Across nine commercial toxin assays, specificity averaged about 95%, so a positive toxin result is meaningful. Sensitivity is the weak spot: conventional toxin immunoassays often catch only about half to four-fifths of true cases, depending on the assay and reference method. A toxin-negative result cannot stand alone either.

Newer ultrasensitive toxin assays close part of that gap. In one 708-person study, single-molecule toxin assays detected about three-quarters of cases in a latent-class model while keeping specificity high. They still cannot classify every person cleanly, because stool toxin levels overlap between symptomatic infection and asymptomatic carriage.

Severity and Recurrence

Among people who are PCR-positive, whether free toxin is also detectable carries prognostic weight. A meta-analysis pooling 46 studies and 33,959 patients found that people who were PCR-positive but toxin-negative had lower rates of recurrence and lower rates of severe infection than people positive on both. Their rates of complications and death, though, were about the same.

That last point is easy to misread, so hold both halves of it. Toxin-negative usually points to a milder course and a lower chance the infection comes back. It does not mean you are safe to ignore. In a large health-system cohort, people who were PCR-positive and toxin-negative sometimes became toxin-positive later, especially after more antibiotics, though the absolute risk of that progression was about 5%.

In children, higher baseline stool toxin concentration predicts recurrence strongly, while links to how severe the first episode is are weaker. In adults, toxin positivity tracks with guideline-defined severe infection but not reliably with the hardest outcomes: colectomy, intensive care, or death.

Strain Matters More Than Toxin A Alone

Some strains simply make far more toxin. The epidemic NAP1/027 strain produced 16-fold more toxin A and 23-fold more toxin B than comparison strains in laboratory culture. In a prospective study of 1,144 people with a first episode, carrying ribotype 027 roughly doubled the odds of death within 30 days and raised the odds of severe infection by about three-quarters, after adjusting for age and other factors. Stool toxin immunoassay positivity, in that same study, predicted neither.

A meta-analysis of 93 studies found a similar pattern: the 027 strain carried roughly double the risk of recurrence, severe outcomes, and attributable death at 30 days. The outcome side of this is less settled than the laboratory side, though. A large propensity-matched Veterans Affairs cohort linked 027 to recurrence but not to severity or death once other factors were balanced, older analyses found the severity gap narrowing after adjusting for age, and at one center the association drifted toward non-027 ribotypes over time. The extra toxin output is well documented; how much of it shows up as worse outcomes depends on the population.

A third toxin, called binary toxin, can also flag worse disease. When it appears alongside a very low eosinophil count, the odds of dying in the hospital rise sharply.

So the practical hierarchy is this. Your symptoms determine whether the result can mean infection. Strain type and free-toxin status help estimate how badly it may go. The toxin A gene result on its own comes at the entry point of that chain, not the end of it.

A Word on Where Toxin A Goes Beyond the Gut

Toxin A does not always stay in the colon. In cell and animal experiments, the toxins drive production of a signaling protein called VEGF-A, which makes blood vessels in the colon leaky. In a small pilot study of 35 people with the infection and 9 healthy donors, toxin was found in blood in most infected participants, and higher serum toxin A levels tracked with more severe disease. Severe cases can involve the heart, kidneys, and nervous system, and circulating toxin is one suspected mechanism, though the human data here are preliminary.

Serum toxin A is not what this stool test measures, and blood toxin testing is not part of routine care. Read that research as an explanation of why severe cases get so sick, not as something to order.

When a Result Can Mislead You

• Testing formed stool: if you are not having loose stools, a positive means carriage, not disease. Labs that accept formed specimens generate false alarms.
• Recent illness rather than current illness: toxin-gene DNA can stay detectable during and after an episode resolves, so a positive PCR weeks after successful treatment does not prove the infection is back.
• Laxatives, tube feeds, and other causes of loose stool: diarrhea from another source in someone who carries C. difficile can produce a positive PCR that has nothing to do with the diarrhea.
• A toxin A result without toxin B: toxin A-negative, toxin B-positive strains can still cause colitis, and they turned up in 2.7% of people with diarrhea in one French survey. A toxin A gene result is best interpreted with toxin B testing.
• A negative toxin-protein assay: free toxin degrades if the sample sits around, and toxin EIAs have limited sensitivity. High-dose corticosteroids or severe leukopenia made false-negative toxin EIAs more likely in one study, so a negative toxin result should not override a convincing clinical picture.

Get the specimen to the lab quickly, especially if your lab also runs a toxin-protein step. And remember the asymmetry: PCR is good at finding toxin-capable organisms, but symptoms decide whether that finding matters.

Repeat Testing, and Why More Is Usually Worse

This is not a marker you trend. Unlike cholesterol or blood sugar, there is no target to move toward. Repeat testing after a proper toxin-gene panel is negative is not recommended in the same episode, because the added yield is small and every extra test raises the chance of a false positive that leads to unnecessary antibiotics.

Do not retest to confirm cure. The gene can persist after your symptoms have resolved, and a positive test-of-cure can lead to a second course of antibiotics you do not need. The signal to track after treatment is your stool frequency and form, not a lab value.

The one situation where retesting makes sense is simple: you finish treatment, get better, and then the diarrhea comes back. Recurrence is common, and a fresh test with symptoms present is appropriate. Otherwise, one test per episode of diarrhea, interpreted against how you actually feel.

What to Do With an Unexpected Result

If a toxin-gene PCR is positive and you have real, ongoing diarrhea, this may need treatment, and that means a prescription. Current adult guidelines suggest fidaxomicin over oral vancomycin when it is available, with oral vancomycin remaining an accepted alternative. The decision should happen promptly, especially if you are older, immunosuppressed, feverish, dehydrated, or worsening.

If PCR is positive and the free-toxin step is negative, the picture is mixed and the decision should turn on how sick you are. Check the rest of the picture: a high white blood cell count, rising creatinine, low albumin, fever, and abdominal pain all push toward treating. Pooled data across studies of PCR-positive, toxin-negative patients found that those who were treated had lower 30-day death from any cause, roughly 5% versus 13%, with no difference in recurrence. Those comparisons are observational rather than randomized, so they argue for a low threshold to treat a sick-looking person, not for treating everyone. A well-looking person with two loose stools and an obvious alternative explanation, like a new laxative or a tube feed, may have colonization. Stool calprotectin or lactoferrin can help. They rise when the gut is inflamed.

If a toxin-gene panel that includes toxin B is negative and you still have diarrhea, this cause is much less likely and the workup moves on: other stool pathogens, inflammatory bowel disease, bile acid diarrhea, celiac disease, medication effects. If you have inflammatory bowel disease, free toxin is detected less often in that group, and telling a flare from an infection often needs a gastroenterologist rather than another stool test.

Anyone with severe abdominal distension, signs of shock, or diarrhea that suddenly stops while the pain worsens needs emergency care immediately, regardless of what any test says. That pattern can mean toxic megacolon.